Filed All Documents. The Company has filed all documents or information required to be filed by it under Canadian Securities Laws, the Securities Act, the Exchange Act, the Rules and Regulations and the rules, regulations and policies of the Exchanges; except as otherwise disclosed on Schedule 5, the Company has not filed any confidential material change report or any document requesting confidential treatment with any securities regulatory authority or regulator or any exchange that at the date hereof remains confidential. Any certificate signed by an authorized officer of the Company and delivered to MLV or to counsel for MLV pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to MLV as to the matters set forth therein.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Cardiome Pharma Corp)
Filed All Documents. The Company has filed all documents or information required to be filed by it under Canadian Securities Laws, the Securities Act, the Exchange Act, the Rules and Regulations and the rules, regulations and policies of the Exchanges; except as otherwise disclosed on Schedule 5, the Company has not filed any confidential material change report or any document requesting confidential treatment with any securities regulatory authority or regulator or any exchange that at the date hereof remains confidential. Any certificate signed by an authorized officer of the Company and delivered to MLV BRFBR or to counsel for MLV BRFBR pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to MLV BRFBR as to the matters set forth therein.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Correvio Pharma Corp.)
Filed All Documents. The Company has filed all documents or information required to be filed by it under Canadian Securities Laws, the Securities Act, the Exchange Act, the Rules and Regulations and the rules, regulations and policies of the Exchanges; except as otherwise disclosed on Schedule 5, the Company has not filed any confidential material change report or any document requesting confidential treatment with any securities regulatory authority or regulator or any exchange that at the date hereof remains confidential. Any certificate signed by an authorized officer of the Company and delivered to MLV the Agent or to counsel for MLV the Agent pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to MLV the Agent as to the matters set forth therein.
Appears in 1 contract
Filed All Documents. The Company has filed all documents or information required to be filed by it under Canadian Securities Laws, the Securities Act, the Exchange Act, the Rules and Regulations and the rules, regulations and policies of the Exchanges; except as otherwise disclosed on Schedule 5, the Company has not filed any confidential material change report or any document requesting confidential treatment with any securities regulatory authority or regulator or any exchange that at the date hereof remains confidential. .
a. Any certificate signed by an authorized officer of the Company and delivered to MLV the Distribution Agents or to counsel for MLV the Distribution Agents pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to MLV the Distribution Agents as to the matters set forth therein.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Cardiome Pharma Corp)